GBIO
Generation Bio Co

897
Loading...
Loading...
Generation Bio Co. is a genetic medicine company, which focuses on creating a new class of gene therapy to provide durable and redosable treatment for patients suffering from both rare and prevalent diseases. Its non-viral platform incorporates a proprietary high-capacity DNA construct called closed-ended DNA, or ceDNA, a novel cell-targeted lipid nanoparticle delivery system, or ctLNP, and an established, scalable capsid-free manufacturing process. The company was founded by Mark D. Angelino, Jason P. Rhodes, and Robert M. Kotin in 2016 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
115

Frequently Asked Questions

What is Market Cap of Generation Bio Co?
What is the 52-week high for Generation Bio Co?
What is the 52-week low for Generation Bio Co?
What is Generation Bio Co stock price today?
What was Generation Bio Co stock price yesterday?
What is the PE ratio of Generation Bio Co?
What is the Price-to-Book ratio of Generation Bio Co?
What is the 50-day moving average of Generation Bio Co?
How many employess does Generation Bio Co has?

Latest GBIO News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.